Supply Chain Intelligence

BioLineRx Ltd. Supply Chain

BLRX supply chain intelligence for BioLineRx Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

BLRX ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
4Customers
1Debt Items
20Related Chains

BioLineRx Ltd. Suppliers

TickerNameConfidenceEvidence
HEMISPHERIAN HEMISPHERIAN 80% In 2025, we entered into a Collaboration Agreement with Hemispherian for the development of GLIX1 via Tetragon.
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from BLRX graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from BLRX graph: Reciprocal relationship from SNYN…
SNYNF Sanofi 72% l and the USA. We also claim common law protections for other marks we use in our business. Competitors and other companies could adopt similar marks or try to prevent us from using our marks, conseq…

BioLineRx Ltd. Customers

TickerNameConfidenceEvidence
AYRMID AYRMID 90% we and Ayrmid entered into a transition services agreement pursuant to which we agreed to provide Ayrmid with certain services related to the development and commercialization of motixafortide within…
HONG-SENG-TECHNOLOGY-LIMITED HONG-SENG-TECHNOLOGY-LIMITED 90% On August 27, 2023, we entered into the Gloria License Agreement, with Hong Seng Technology Limited, or HST, and Gloria, and/or with HST, the Gloria Licensee, pursuant to which we granted HST an excl…
SNYNF Sanofi 72% l and the USA. We also claim common law protections for other marks we use in our business. Competitors and other companies could adopt similar marks or try to prevent us from using our marks, conseq…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from BLRX graph: l and the USA. We also claim common law protections for other marks we use in our business. Competitors and other co…

BioLineRx Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
BLRX-DEBT Debt stack $10.2M 90% Market cache reports total debt of $10.2M.

BioLineRx Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for BioLineRx Ltd..

BioLineRx Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for BioLineRx Ltd..

BioLineRx Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SVA Sinovac Biotech Ltd. 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
TECX Tectonic Therapeutic, Inc. 100.00 2
View BLRX supply chain intel →

Explore the full interactive supply chain map for BioLineRx Ltd..

Open BLRX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map